Jadran Galenski Laboratorij

By consolidating and analyzing both external market and internal planning data, this European pharma company gains a 360-degree view of its production environment, enabling it to predict and respond quickly to fluctuations and changes

Published on 16-Sep-2011

Validated on 17 Dec 2013

"Improved visibility and understanding of data gives us full control over the planning cycle, enabling optimization of procurement and production, and continued growth and lower costs for the company." - Elvedina Kežman, CRM and Marketing Controlling Manager

Customer:
Jadran Galenski Laboratorij

Industry:
Chemicals & Petroleum, Healthcare, Life Sciences

Deployment country:
Croatia

Solution:
Application Design-Build-Manage, BA - Business Analytics, BA - Business Intelligence, Business Performance Transformation, C-Suite Framework, Data Warehouse, Smart Work, Smarter Planet, Business-to-Business, Center for Business Optimization (CBO)")

Smarter Planet:
Smarter Healthcare

IBM Business Partner:
Poslovna inteligencija d.o.o.

Overview

Jadran Galenski Laboratorij (JGL) is one of the leading Croatian pharmaceutical companies, headquartered in Rijeka. From 1991 to date, thanks to its innovative strategies, the company has been continuously growing. Over the last 10 years, registered annual revenue growth rate has never been less than 25 percent and in the last three years it even exceeded 30 percent. JGL, as a propulsive regional pharmaceutical company, aims to develop its market position in the countries of Southeast, Central and Eastern Europe and CIS countries by introducing its own key brands to the global health market.

Business need:
This European pharmaceutical company was experiencing rapid growth that was not supported by its existing controlling processes. The company’s budgeting and forecasting processes were manual, time-consuming and labor-intensive. Reporting, planning and forecasting were difficult and often inaccurate because data was scattered across the company, which lacked a single view of market data, competitors, procurement and production information. The company needed to implement a fact-driven planning process enabled by an in-depth analysis of all available data.

Solution:
Companies can gain an unprecedented ability to respond quickly to market and internal changes, and take the guesswork out of planning and forecasting, by being able to analyze all factors, internal and external, influencing their business environment. With a single, 360-degree view of its competitors, the marketplace and its own internal information, this pharmaceutical company can now analyze, predict and react when, for example, sales decline because of market factors (for example, a competitor lowers their price) or there are delays in production due to procurement issues.

Benefits:
• Increases agility by reducing the planning cycle by 25 percent • Reduces the time for data analysis and data quality review by 34 percent, and for analysis and data integration by 28 percent, enabling greater focus responding to the market, and growing the business further • Reduces risk and unnecessary cost by enabling corrective and predictive actions based on analyzed information

Case Study

Jadran Galenski Laboratorij (JGL) is one of the leading Croatian pharmaceutical companies, headquartered in Rijeka. From 1991 to date, thanks to its innovative strategies, the company has been continuously growing. Over the last 10 years, registered annual revenue growth rate has never been less than 25 percent and in the last three years it even exceeded 30 percent. JGL, as a propulsive regional pharmaceutical company, aims to develop its market position in the countries of Southeast, Central and Eastern Europe and CIS countries by introducing its own key brands to the global health market. The company’s strategy of fast growth has been based on the development of its own brand of generic drugs and a consumer healthcare program, as well as on strategic partnerships with some of the major pharmaceutical companies in development, production and marketing.

The Opportunity
This European pharmaceutical company was experiencing rapid growth that was not supported by its existing controlling processes. The company’s budgeting and forecasting processes were manual, time-consuming and labor-intensive. Reporting, planning and forecasting were difficult and often inaccurate because data was scattered across the company, which lacked a single view of market data, competitors, procurement and production information. The company needed to implement a fact-driven planning process enabled by an in-depth analysis of all available data.

What Makes it Smarter
Companies can gain an unprecedented ability to respond quickly to market and internal changes, and take the guesswork out of planning and forecasting, by being able to analyze all factors, internal and external, influencing their business environment. With a single, 360-degree view of its competitors, the marketplace and its own internal information, this pharmaceutical company can now analyze, predict and react when, for example, sales decline because of market factors (for example, a competitor lowers their price) or there are delays in production due to procurement issues. The company can respond quickly and change its production planning process, and better plan inventories and product lines based on the most up-to-date information available. The company is now operating in a fact-driven corporate culture that positions it to continue its strong growth trajectory.

Real Business Results
• Increases agility by reducing the planning cycle by 25 percent
• Reduces the time for data analysis and data quality review by 34 percent, and for analysis and data integration by 28 percent, enabling greater focus responding to the market, and growing the business further
• Reduces risk and unnecessary cost by enabling corrective and predictive actions based on analyzed information

For more information
Please contact your IBM sales representative or IBM Business Partner. Visit us at: ibm.com/lifesciences


To learn more about Jadran Galenski Laboratorij visit: www.jgl.hr

Products and services used

IBM products and services that were used in this case study.

Hardware:
Storage: DS3950, System x: System x running Windows, System x: System x3650 M3

Software:
Cognos Business Intelligence, Cognos 8 Planning

Service:
GBS BAO: Advanced Analytics and Optimization, GBS BAO: Business Intelligence and Performance Management, GBS Strategy and Change: Business Strategy

Legal Information

© Copyright IBM Corporation 2011 IBM Corporation 1 New Orchard Road Armonk, NY 10504 U.S.A. Produced in the United States September 2011 All Rights Reserved IBM, the IBM logo, ibm.com, Cognos, Global Business Services and System x are trademarks of International Business Machines Corporation, registered in many jurisdictions worldwide. A current list of IBM trademarks is available on the Web at “Copyright and trademark information” at ibm.com/legal/copytrade.shtml Other company, product or service names may be trademarks or service marks of others. The information contained in this documentation is provided for informational purposes only. While efforts were made to verify the completeness and accuracy of the information contained in this documentation, it is provided “as is” without warranty of any kind, express or implied. In addition, this information is based on IBM’s current product plans and strategy, which are subject to change by IBM without notice. IBM shall not be responsible for any damages arising out of the use of, or otherwise related to, this documentation or any other documentation. Nothing contained in this documentation is intended to, nor shall have the effect of, creating any warranties or representations from IBM (or its suppliers or licensors), or altering the terms and conditions of the applicable license agreement governing the use of IBM software.